Medtech Money

In this episode, Giovanni Lauricella and Peter Vranes discuss his background as an entrepreneur, how they founded Nutromics, what the company is doing, where does Australia fit in the global MedTech industry, the advantageous clinical trial environment in Australia, their experience raising capital and closing their most recent round, the lack of investors and how that affects startups in Australi...

In this episode, Giovanni Lauricella and Cristiano Fontana discuss how they came up with the name Three Bridges M&C, his background in the medical device and how he works with early stage startups to fill their gaps, differences in raising money from different kinds of investors, pre-market evaluations, why evaluations are so high, discussing why company evaluations change country to country,...

In this episode, Giovanni Lauricella and Janelle Goulard discuss her background in the healthtech space, their focus around advanced materials, why they invest in hardtech, their average check size, what geographies they invest in, the evolution of their five funds, the exit times in Medtech and why that influenced them to move to later stage, their preference of how deal flow comes to them, and s...

In this episode, our host Giovanni Lauricella and our guest Daniel Hawkins from Avail Medsystems discuss his $100 million raise, his experience at Intuitive Surgical and what it was like to be employee number 6, his exit to Johnson and Johnson, his experience in raising money at Sofinova, his promise he made to investors, he discusses his strategy around IP with his companies, how he raised $100 m...

In this episode, Giovanni and Ahmed discuss how far $14,000 can go if you are capital efficient, the bioenter program at University of California - Irvine, how he founded his company, how he raised their initial sum of money, the importance of constant communication with investors, and so much more. Ahmed Zobi LinkedIn Syntr Health Technologies Website Giovanni Lauricella LinkedIn Project Medtech...

In this episode, Giovanni and Eyal discuss the fascinating reason why they chose the name Peregrine Ventures, his history in the Medtech space, where their various funds invest in the lifecycle of a Medtech company, comparing Israel to the other health science startup hubs, the future of Israel and how it will center around manufacturing technology, and so much more. Eyal Lifschitz LinkedIn Peregr...

In this episode, Giovanni and Juan discuss how they came up with the name, Keiretsu Forum, how the group was founded, the size of their group, the number of deals they do a year, the various skills that you should develop as a Medtech Startup CEO, how much they typically invest and when they can expect the money to hit the bank account, why selling is so important as an entrepreneur and so much mo...

In this episode, Giovanni, Emily and David discuss grand funding from the NIH, the small business funding group she oversees, her background in the health tech space, why entrepreneurs might want to get non-dilutive NIH funding, the mechanics of how this non-dilutive funding works, the blueprint Medtech program, how they provide access to resources, and so much more. Emily Caporello LinkedIn David...

In this episode, Giovanni and Gautam discuss “doing the right the thing” and the good karma it will bring, his role at The Capital Partnership, the typical check size of each of their funds, where he sees the Medtech space going in the future, their strategy when investing in companies, their connection to Schfimed companies, where there current investments have been, why they invest so heavily in...

In this episode, Giovanni and Anne discuss Sofinnova and where they focus their investments, MD Start and the relationship between MD Start and Sofinnova, her new start-up company called Moon Surgical, being with something from inception through exit and how that math works from an investment side, and more. Anne Osdoit LinkedIn Sofinnova Website Giovanni Lauricella LinkedIn Project Medtech Linked...

In this episode, Giovanni and Sascha discuss how he became the Managing Partner at SHS, where they focus from a stage of company and geographical area, the hardline of having revenue before they invest, the major differences of going public in the US and Europe for later stage companies, the affect of EU MDR on the region and innovation, their due diligence process, and more. Sascha Alilovic Linke...

In this episode, Giovanni and Juan discuss how the name of Action Potential Venture Capital came about, what kind of technology they focus in and how they choose their investments, what round they prefer to invest, how does being a corporate venture capital firm acting as traditional venture capital group affect their investment, and more. Juan Cueva LinkedIn Action Potential Venture Capital Websi...

In this episode, Giovanni and James discuss creating a culture at a start-up that people want to be a part of, how he founded Access Vascular, why doing sales was important for his success as a Medtech CEO, the ability to find and fill the gaps as a Medtech startup, how he raised money for Access Vascular, his tips for Medtech companies for overall success and success in raising capital, and more....

In this episode, Giovanni and Yoav discuss what Health IL is, how are they funded and what their focus is, how they work with Israel startup companies, what makes Israel so special, what is Israel’s limitations, and more. Yoav Fisher LinkedIn HealthIL Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

In this episode, Giovanni and Oliver discuss corporate venture, how Intuitive works with startups in the Medtech space, how they invest, the due diligence process from a strategic vs. venture capital group, how they evaluate potential investments, future funds, and more. Oliver Keown LinkedIn Intuitive Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

In this episode, Giovanni and Lucien discuss raising capital from China, China’s massive interventional cardiology market, how they used Mavie to help raise capital in China, the timeline of raising capital, their relationship with Microport, what value does an investment banker bring, and more. Lucien Goffart LinkedIn Robocath Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project...

In this episode, Giovanni and Thom discuss what it is like to be a venture capital group in Europe, how the MDR is affecting Medtech deal flow, where they focus their investments, the importance of the experience of selling something, the similarities between marketing and venture capital, and more. Thom Rasche LinkedIn Earlybird Venture Capital Website Giovanni Lauricella LinkedIn Project Medtech...

In this episode, Giovanni and John discuss his role and what they do at Accelmed, what is private equity, the difference between private equity vs. venture capital, what they look for in an investment, and more. John Gillings LinkedIn Accelmed Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

In this episode, Giovanni and Zied discuss raising capital as an early stage start-up in Europe, the various challenges of being a Medtech CEO, his personal connection to the technology, and more. Zied Tayeb LinkedIn Myelin-H Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

In this episode, Giovanni and Howard discuss how he got into the medical technology space, the technology his team is working on at Lumiheal, how his background as a lawyer has helped him run his company thus far, negotiating terms with initial investors, difference between late stage and early stage investing, success being more important than dilution, the importance of networking as a CEO, and...

In this episode, Giovanni and Kelly discuss what he is currently working on at Fisher Wallace Laboratories, why he chose crowd funding as a source of capital for his Medtech start-up, how to crowd fund, what you need to do with the SEC, which platform they used and why they chose it, and more. Kelly Roman LinkedIn Fisher Wallace Laboratories Website Giovanni Lauricella LinkedIn Project Medtech Lin...

In this episode, Giovanni and Howard discuss being a part of Life Science Angels, what his team is working on at Tesa Medical, the mechanics of how angels invest, the different strategies they employ, safes vs. notes, price rounds, and more. Howard Edelman LinkedIn Life Science Angels Website Business Wire for Tesa Medical Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Websi...

In this episode, Giovanni and Olivier discuss how Andera Partners was founded, when they invest in companies, how they build their portfolio of companies, how they have continued to invest in small companies with being such a large fund, what kind of companies they invest in, and more. Olivier Litzka LinkedIn Andera Partners Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Med...

In this episode, Giovanni and Charlie discuss what they are doing at Modulim, the first money that came in the door, their different rounds of funding, how they made non-dilutive funding last so long, when it makes sense to pursue non-dilutive funding, why the name of your round matters, and more. Charlie Huiner LinkedIn Modulim Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project...

In this episode, Giovanni and Jen discuss how she got involved in the space, what her fund invests in, contrasting time to exit for Biotech vs. Medtech, failure rates of an investment in Medtech, the MDR and how it is affecting deal flow in Europe, the Medtech ecosystem in Ireland, women in Medtech and more. Jennifer McMahon LinkedIn Seroba Life Sciences Website Giovanni Lauricella LinkedIn Projec...